Neuraxpharm standardizes real‑time data exchange across its global supply chain network
The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestration
24 Dec 2025
TraceLink has announcesd that Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has gone live on the TraceLink network with Multienterprise Information Network Tower (MINT), powered by Orchestration Platform for Universal Solutions (OPUS).
To reduce product lead times, improve orchestration between contract manufacturing organizations (CMOs), third-party logistics providers, and customers, and avoid lost sales and increased warehouse costs, Neuraxpharm required a more agile, transparent, and scalable supply chain network for real‑time collaboration across its global partners.
Managing more than 3,000 stock keeping units across over 100 markets, the company faced increasing complexity in coordinating production, logistics, and procurement activities with hundreds of partners operating on different enterprise resource planning (ERP) systems and communication tools.
Essential supply chain information — such as purchase orders, delivery confirmations, and shipping updates — was historically exchanged through emails, spreadsheets, and phone calls. These challenges created pockets of operational inefficiency, affecting lead times, warehouse costs, and real-time visibility.
Manual oversight added extra steps and increased the likelihood of minor delays or discrepancies, which could influence product availability and net sales.
With MINT, Neuraxpharm has unified its diverse partner ecosystem through a single network-based architecture that digitalizes key processes and enables mission-critical data — such as forecasts, purchase orders, and confirmations — to flow in real time directly between ERP systems, ensuring that all parties operate from one source of truth.
After the first live implementation phase, Neuraxpharm shared that internal demand forecasts — previously exchanged manually — are now automatically transferred to the CMO's ERP system within minutes of internal approval, significantly reducing turnaround time and minimizing the risk of manual discrepancies.
A central driver in Neuraxpharm's selection of TraceLink was the B2N Integrate-Once™ model, which enables partners to link just once to the TraceLink network, eliminating the need to maintain multiple integrations, set up new point-to-point connections, or manage evolving data formats. This streamlined approach provides no-cost access to more than 291,000 authenticated trading partners worldwide.
This model also significantly reduces IT resource strain and has full support from Neuraxpharm's IT and leadership teams, who view the MINT‑enabled digitalization strategy as a natural complement to the existing tech stack.
"Organizations like Neuraxpharm demonstrate what the future of the supply chain looks like — integrated, collaborative, and guided by real-time data and intelligence," said Shabbir Dahod, President and CEO of TraceLink. "The companies that will lead the next era are those investing in network-based data foundations that enable AI to anticipate issues, automate decision-making, and ensure medicines reach patients without disruption."